☆ 4.8 Article

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

NATURE COMMUNICATIONS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

Hung Fu Tseng et al.

Summary: A test-negative case-control analysis using data from a diverse population in California, USA, demonstrates that vaccine efficacy of a three-dose regimen of the mRNA-1273 COVID-19 vaccine is reduced against infection with the Omicron SARS-CoV-2 variant in comparison to Delta, but that efficacy against hospitalization remained high for both variants.

NATURE MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Letter Medicine, General & Internal

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection

Heba N. Altarawneh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Immunology

Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant

Adeel A. Butt et al.

Summary: According to data from the National COVID-19 Database in Qatar, Omicron variant infection causes milder disease in children/adolescents compared to Delta variant infection, as reflected by lower hospitalization rates and the need for intensive care unit (ICU) care or mechanical ventilation. Children aged 6 to <18 also have less severe disease compared to those younger than 6 years old.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Editorial Material Infectious Diseases

Effectiveness of BNT162b2 against COVID-19 in adolescents

Annabel A. Powell et al.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar

L. J. Abu-Raddad et al.

Summary: A study in Qatar showed that booster vaccination significantly reduced the incidence of infection with the omicron variant, providing strong protection against Covid-19-related hospitalization and death. Booster effectiveness was observed for both mRNA vaccines, BNT162b2 and mRNA-1273, with lower infection rates and reduced severity of cases among those who received the booster dose.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

添加到收藏夹

Article Medicine, General & Internal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Hiam Chemaitelly et al.

Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al.

Summary: The study found that the mortality hazard ratio associated with infection with VOC-202012/1 compared with previously circulating variants was 1.64, indicating an increase in deaths from 2.5 to 4.1 per 1000 detected cases in comparatively low risk group of covid-19 patients in the community. This suggests that infection with VOC-202012/1 may lead to substantial additional mortality compared with previously circulating variants, impacting healthcare capacity planning and control policies.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19

Houssein H. Ayoub et al.

Summary: Mathematical modeling and forecasting successfully guided Qatar's national response to the epidemic, effectively reducing the impact on the healthcare system and bringing the epidemic under control.

JOURNAL OF GLOBAL HEALTH (2021)

添加到收藏夹

Article Medicine, General & Internal

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study

Laith J. Abu-Raddad et al.

Summary: The novel SARS-CoV-2 variant B.1.1.7 (Alpha) can cause a significant epidemic wave when introduced into a naive population, but individuals with prior infections have strong immunity against reinfection with B.1.1.7.

PLOS MEDICINE (2021)

添加到收藏夹

Article Immunology

One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar

Fatiha M. Benslimane et al.

Summary: "The study in Qatar revealed a diverse range of virus lineages during the COVID-19 outbreak, indicating local transmission chains and emergence of new mutations. Continued genomic surveillance is crucial for monitoring the changes in SARS-CoV-2 in Qatar."

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

Laith J. Abu-Raddad et al.

Summary: The study provided descriptive epidemiology of the SARS-CoV-2 epidemic in Qatar, showing age as the strongest predictor of severe, critical, or fatal infection. Most cases were asymptomatic. The rapid decline in cases was attributed to the growing immunity levels in the population.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Immunology

SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar

Mohamed H. Al-Thani et al.

Summary: Six in every 10 craft and manual workers in Qatar have been infected with COVID-19, suggesting the herd immunity threshold has been reached. The severity rate of infections was low, with the majority of infections being asymptomatic or mild.

OPEN FORUM INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar

Mohammad R. Hasan et al.

Summary: This study successfully characterized the transmission dynamics of the Alpha, Beta, and Delta variants of SARS-CoV-2 in Qatar between April and June 2021 using PCR genotyping and Sanger sequencing techniques.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Editorial Material Public, Environmental & Occupational Health

Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses

Laith J. Abu-Raddad et al.

JOURNAL OF TRAVEL MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar

Hiam Chemaitelly et al.

Summary: A study showed that the mRNA-1273 vaccine is highly effective against the B.1.1.7 and B.1.351 variants of concern, with efficacy rates of 100% and 96.4% respectively. The vaccine's effectiveness increases rapidly in the weeks following the first dose, reaching maximum efficacy after the second dose, providing strong protection against severe COVID-19 outcomes.

NATURE MEDICINE (2021)

添加到收藏夹

Article Environmental Sciences

COVID-19 (SARS-CoV-2) outbreak monitoring using wastewater-based epidemiology in Qatar

Jayaprakash Saththasivam et al.

Summary: Sampling raw wastewater from major treatment plants in Qatar, it was found that there was a significant discrepancy between the estimated number of infected people and the officially reported cases. Wastewater-based epidemiology proved to be a more reliable method for assessing the true incidence trend in the population.

SCIENCE OF THE TOTAL ENVIRONMENT (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar

Shaheen Seedat et al.

Summary: The study shows a significant age dependence in the severity and fatality rates of SARS-CoV-2, with higher risks for older age groups. Despite Qatar's young population, if the demographic structure were similar to Europe or the United States, the disease burden would be much higher.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals

Peter Coyle et al.

Summary: The study found that less than two in every 10 individuals in Qatar's urban population had detectable antibodies against SARS-CoV-2, indicating that herd immunity is still far off and there is a risk of subsequent infection waves. Higher antibody titers may serve as a biomarker of repeated exposures to the infection.

ISCIENCE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women

Adeel A. Butt et al.

Summary: The study found that mRNA vaccines provide a high level of protection against documented SARS-CoV-2 infection during pregnancy. This supports the inclusion of pregnant women in vaccination campaigns.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A model and predictions for COVID-19 considering population behavior and vaccination

Thomas Usherwood et al.

Summary: The model explores the relationship between vaccination effectiveness and population behavior response, predicting COVID-19 infection trends and highlighting the impact of vaccination rate and changes in people's sense of safety on epidemic control.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Editorial Material Immunology

Depletion-of-susceptibles Bias in Analyses of Intra-season Waning of Influenza Vaccine Effectiveness

G. Thomas Ray et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Immunology

Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses

Monia Makhoul et al.

VACCINES (2020)

添加到收藏夹

Review Immunology

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

Jennifer R. Verani et al.

VACCINE (2017)

添加到收藏夹

Article Medicine, General & Internal

Analysis of matched case-control studies

Neil Pearce

BMJ-BRITISH MEDICAL JOURNAL (2016)

添加到收藏夹

Article Medicine, General & Internal

Analysis of matched case-control studies

Neil Pearce

BMJ-BRITISH MEDICAL JOURNAL (2016)

添加到收藏夹

Letter Immunology

Is it necessary to adjust for calendar time in a test negative design? Responding to: Jackson L, Nelson JC. The test negative design for estimating influenza vaccine effectiveness. Vaccine 2013;31(April (17)):2165-8

Peter Jacoby et al.

VACCINE (2014)

添加到收藏夹

Article Immunology

The test-negative design for estimating influenza vaccine effectiveness

Michael L. Jackson et al.

VACCINE (2013)

添加到收藏夹

Article Statistics & Probability

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

Peter C. Austin

COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION (2009)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.